Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis

Journal of Clinical Oncology

Volumn 18, Issue 6, 2000, Pages 1220-1229

  Whelan, Timothy J ^a   Julian, Jim ^a   Wright, Jim ^a   Jadad, Alejandro R ^a   Levine, Mark L ^a  

^a CANCER CARE ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FLUOXYMESTERONE; LEVAMISOLE; MELPHALAN; METHOTREXATE; PREDNISONE; TAMOXIFEN; TEGAFUR; VINCRISTINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MEGAVOLTAGE RADIATION; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME;

EID: 0034063101     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.6.1220     Document Type: Article

References (60)

1. Cuzick J, Stewart H, Rutqvist L, et al: Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447-453, 1994
2. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med 333:1444-1455, 1995
3. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949-955, 1997
4. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
5. Overgaard M, Jensen MB, Overgaard J, et al: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641-1648, 1999
6. Hellman S: Stopping metastases at their source. N Engl J Med 337:996-997, 1997
7. Recht A, Bartelink H, Fourquet A, et al: Postmastectomy radiotherapy: Questions for the twenty-first century. J Clin Oncol 16:2886-2889, 1998
8. Valagussa P, Zambetti M, Biasi A, et al: Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer. Ann Oncol 5:209-216, 1994
9. Shapiro CL, Hardenbergh PH, Gelma R, et al: Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 16:3493-3501, 1998
10. Curtis RE, Boice JD Jr, Stoval M, et al: Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326:1745-1751, 1992
11. Swedborg I, Wallgren A: The effect of pre- and postmastectomy radiotherapy on the degree of edema, shoulder-joint mobility, and gripping force. Cancer 47:877-881, 1981
12. Larson D, Weinstein M, Goldberg I, et al: Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 12:1575-1582, 1986
13. Tobin MB, Lacey HJ, Meyer L, et al: The psychological morbidity of breast cancer-related arm swelling: Psychological morbidity of lymphoedema. Cancer 72:3248-3252, 1993
14. Buzdar AU, Hortobagyi GN, Kau S-W, et al: Breast cancer adjuvant therapy trials of M. D. Anderson Hospital: Results of three studies, in Salmon SE (ed): Adjuvant Therapy of Cancer V. Orlando, FL, Grune & Stratton, 1987, pp 411-418
15. Spangenberg JP, Nel CJ, Anderson JD, et al: A prospective study of the treatment of stage III breast cancer. S Afr J Surg 24:57-60, 1986
16. Schulz K-D, Reusch K, Schmidt-Rhode P, et al: Consecutive radiation and chemotherapy in the adjuvant treatment of operable breast cancer, in Salmon SE, Jones SE (eds): Adjuvant Therapy of Cancer III. New York, Grune & Stratton, 1981, pp 411-418
17. Liberati A, Himel HN, Chalmers TC: A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol 4:942-951, 1986
18. Jadad AR, Moore RA, Carrol D, et al: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12, 1996
19. Woolf B: On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253, 1955
20. Laird NM, Mosteller F: Some statistical methods for combining experimental results. Int J Technol Assess Health Care 6:5-30, 1990
21. Berkey CS, Hoaglin DC, Mosteller F, et al: A random-effects regression model for meta-analysis. Stat Med 14:395-411, 1995
22. DeBoer G, Paterson AHG, Pritchard KI: [unpublished study], in Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med 333:1444-1455, 1995
23. Foroglou P, Giokas G, Lissaios B: [unpublished study], in Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med 333:1444-1455, 1995
24. Grohn P, Heinonen E, Klefstrom P, et al: Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. Cancer 54:670-674, 1984
25. Klefstrom P, Grohn P, Heinonen E, et al: Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer: II. 5-year results and influence of levamisole. Cancer 60:936-942, 1987
26. Tramprisch HJ: [unpublished study], in Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med 333:1444-1455, 1995
27. Blomqvist C, Tiusanen K, Elomaa I, et al: The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicinfluorouracil) and tamoxifen in stage II breast cancer: Long-term follow-up results of a randomized trial. Br J Cancer 66:1171-1176, 1992
28. Hayat H, Brufman G, Borovik R, et al: Adjuvant chemotherapy and radiation therapy vs chemotherapy alone for stage II breast cancer patients: A national randomized trial. Ann Oncol 1:21, 1990 (suppl, abstr)
29. Amparo M, Gervasio H, Albano J, et al: Adjuvant chemotherapy versus radiotherapy and chemotherapy in operable breast cancer with positive nodes: Results at 14 years of a randomized trial. Ann Oncol 5:16, 1994 (suppl 8, abstr)
30. Gervasio H, Alves H, Rito A, et al: Phase III study: Adjuvant chemotherapy versus adjuvant radiotherapy plus chemotherapy in women with node-positive breast cancer. Breast J 4:S88, 1998 (suppl 1, abstr)
31. Cooper MR, Rhyne AL, Muss HB, et al: A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast cancer. Cancer 47:2833-2839, 1981
32. Muss HB, Cooper MR, Brockschmidt JK, et al: A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer: Eleven year follow-up of a Piedmont Oncology Association trial. Breast Cancer Res Treat 19:77-84, 1991
33. Schmoor C, Bastert G, Bojar H, et al: Effect of radiotherapy in addition to 6 cycles CMF in node positive breast cancer patients: German Breast Cancer Study Group (GBSG). Eur J Cancer 34:S59, 1998 (suppl 5, abstr)
34. Griem KL, Henderson IC, Gelman R, et al: The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 5:1546-1555, 1987
35. McArdle CS, Calman KC, Cooper AF, et al: The social, emotional and financial implications of adjuvant chemotherapy in breast cancer. Br J Surg 68:261-264, 1981
36. McArdle CS, Crawford D, Dykes EH, et al: Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 73:264-266, 1986
37. Vélez-Garcia E, Carpenter JT, Moore M, et al: Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: The South-Eastern Cancer Study Group (SECSG) Experience, in Jones SE, Salmon SE (eds), Adjuvant Therapy of Cancer IV. Orlando, FL, Grune & Stratton, 1984, pp 273-282
38. Vélez-Garcia E, Moore M, Vogel CL, et al: Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: The Southeastern Cancer Study Group experience. Breast Cancer Res Treat, 3:49-60, 1983 (suppl 1)
39. Vélez-Garcia E, Carpenter JT, Moore M, et al: Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: Progress report of a South-Eastern Cancer Study Group (SEG) Trial, in Salmon SE (eds), Adjuvant Therapy of Cancer V. Orlando, FL, Grune & Stratton, 1987, pp 347-355
40. Vélez-Garcia E, Carpenter JT, Moore M, et al: Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: A South-Eastern Cancer Study Group (SEG) Trial. Eur J Cancer 28A:1833-1837, 1992
41. Ahmann DL, O'Fallon JR, Scanlon PW, et al: A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy. J Clin Oncol 5:371-381, 1982
42. Martinez A, Ahmann D, O'Fallon J, et al: An interim analysis of the randomized surgical adjuvant trial for patients with unfavorable breast cancer. Int J Radiat Oncol Biol Phys 10:106, 1984 (abstr)
43. Olson JE, Neuberg D, Pandya KJ, et al: The role of radiotherapy in the management of operable locally advanced breast carcinoma: Results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer 79:1138-1149, 1997
44. Arwidi A, Aspegren K, Augustsson N-E, et al: Postoperative radiation therapy in mammary carcinoma stage II: Target volume, organs at risk, absorbed dose, time-dose schedule, and dose to organs at risk in a prospective investigation. Acta Radiol Oncol Radiat Phys Biol 18:273-281, 1979
45. Ryden S, Ferno M, Moller T, et al: Long-term effects of adjuvant tamoxifen and/or radiotherapy: The South Sweden Breast Cancer Trial. Acta Oncol 31:271-274, 1992
46. Tennvall-Nittby L, Tengrup I, Landberg T: The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. Acta Oncol 32:641-646, 1993
47. Overgaard M, Christensen JJ, Johansen H: Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG 82) trial. Int J Radiat Oncol Biol Phys 19:1121-1124, 1990
48. Mouridsen HT, Rose C, Overgaard M, et al: Adjuvant treatment of postmenopausal patients with high risk primary breast cancer: Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C. Acta Oncol 27:699-705, 1988
49. Højris I, Overgaard M, Christensen JJ, et al: Morbidity and mortality of ischemic heart disease in 3083 high-risk breast cancer patients given adjuvant systemic treatment with or without postmastectomy irradiation. Radiother Oncol 48:S120, 1998 (suppl 1, abstr)
50. Haybittle JL, Brinkley D, Houghton J, et al: Postoperative radiotherapy and late mortality: Evidence from the Cancer Research Campaign trial for early breast cancer. BMJ 298:1611-1614, 1989
51. Rutqvist LE, Lax I, Fornander MD, et al: Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 22:887-896, 1992
52. Jadad AR, Cook DJ, Browman GP: A guide to interpreting discordant systematic reviews. CMAJ 156:1411-1416, 1997
53. Fuller SA, Haybittle JL, Smith REA, et al: Cardiac doses in post-operative breast irradiation. Radiother Oncol 25:19-24, 1992
54. Jones JM, Ribeiro GG: Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol 40:204-208, 1989
55. Recht A, Come SE, Gelman RS, et al: Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage node-positive breast cancer: Sequencing, timing, and outcome. J Clin Oncol 9:1662-1667, 1991
56. Buchholz TA, Austin-Seymour MM, Moe RE, et al: Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 26:23-35, 1993
57. Stewart LA, Parmar MK: Meta-analysis of the literature or of individual patient data: Is there a difference? Lancet 341;418-422, 1993
58. Oxman AD, Clarke MJ, Stewart LA: From science to practice: Meta-analyses using individual patient data are needed. JAMA 274: 845-846, 1995
59. Cuzick, Stewart H, Peto R, et al: Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 71:15-29, 1987
60. Hellman S: Natural history of small breast cancers. J Clin Oncol 12:2229-2234, 1994